About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Anti-Inflammatory Therapeutics Market Size, Growth, Analysis, Share to [2022-2030]

Anti-Inflammatory Therapeutics Market

Anti-Inflammatory Therapeutics Market Size, Share & Trends Analysis Report By Drug Class (Nonsteroidal Anti-Inflammatory Drugs, Corticosteroids, Biologics), By Indications (Arthritis, Psoriasis, Respiratory Diseases, Multiple Sclerosis, Anti-inflammatory Bowel Disease, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2022-2030

Report Code: SRHI3398DR
Study Period 2018-2030 CAGR 3.8%
Historical Period 2018-2020 Forecast Period 2022-2030
Base Year 2021 Base Year Market Size USD 101.21 Billion 
Forecast Year 2030 Forecast Year Market Size USD 141.58 Billion
Largest Market North America Fastest Growing Market Europe 
Show More
Buy Now
File Formats
The sample report only takes 30 secs to download, no need to wait longer.

Market Segmentation

  1. Anti-Inflammatory Therapeutics Market, By Drug Class (2020-2030)
    1. Nonsteroidal Anti-Inflammatory Drugs
    2. Corticosteroids
    3. Biologics
  2. Anti-Inflammatory Therapeutics Market, By Indications (2020-2030)
    1. Arthritis
    2. Psoriasis
    3. Respiratory Diseases
    4. Multiple Sclerosis
    5. Anti-inflammatory Bowel Disease
    6. Others
    1. North America
      1. North America Anti-Inflammatory Therapeutics Market, By Drug Class
        1. Nonsteroidal Anti-Inflammatory Drugs
          1. Corticosteroids
            1. Biologics
            2. North America Anti-Inflammatory Therapeutics Market, By Indications
              1. Arthritis
                1. Psoriasis
                  1. Respiratory Diseases
                    1. Multiple Sclerosis
                      1. Anti-inflammatory Bowel Disease
                        1. Others
                        2. U.S.
                          1. U.S. Anti-Inflammatory Therapeutics Market, By Drug Class
                            1. Nonsteroidal Anti-Inflammatory Drugs
                              1. Corticosteroids
                                1. Biologics
                                2. U.S. Anti-Inflammatory Therapeutics Market, By Indications
                                  1. Arthritis
                                    1. Psoriasis
                                      1. Respiratory Diseases
                                        1. Multiple Sclerosis
                                          1. Anti-inflammatory Bowel Disease
                                            1. Others
                                          2. Canada
                                        2. Europe
                                          1. Europe Anti-Inflammatory Therapeutics Market, By Drug Class
                                            1. Nonsteroidal Anti-Inflammatory Drugs
                                              1. Corticosteroids
                                                1. Biologics
                                                2. Europe Anti-Inflammatory Therapeutics Market, By Indications
                                                  1. Arthritis
                                                    1. Psoriasis
                                                      1. Respiratory Diseases
                                                        1. Multiple Sclerosis
                                                          1. Anti-inflammatory Bowel Disease
                                                            1. Others
                                                            2. U.K.
                                                              1. U.K. Anti-Inflammatory Therapeutics Market, By Drug Class
                                                                1. Nonsteroidal Anti-Inflammatory Drugs
                                                                  1. Corticosteroids
                                                                    1. Biologics
                                                                    2. U.K. Anti-Inflammatory Therapeutics Market, By Indications
                                                                      1. Arthritis
                                                                        1. Psoriasis
                                                                          1. Respiratory Diseases
                                                                            1. Multiple Sclerosis
                                                                              1. Anti-inflammatory Bowel Disease
                                                                                1. Others
                                                                              2. Germany
                                                                              3. France
                                                                              4. Spain
                                                                              5. Italy
                                                                              6. Russia
                                                                              7. Nordic
                                                                              8. Benelux
                                                                              9. Rest of Europe
                                                                            2. APAC
                                                                              1. APAC Anti-Inflammatory Therapeutics Market, By Drug Class
                                                                                1. Nonsteroidal Anti-Inflammatory Drugs
                                                                                  1. Corticosteroids
                                                                                    1. Biologics
                                                                                    2. APAC Anti-Inflammatory Therapeutics Market, By Indications
                                                                                      1. Arthritis
                                                                                        1. Psoriasis
                                                                                          1. Respiratory Diseases
                                                                                            1. Multiple Sclerosis
                                                                                              1. Anti-inflammatory Bowel Disease
                                                                                                1. Others
                                                                                                2. China
                                                                                                  1. China Anti-Inflammatory Therapeutics Market, By Drug Class
                                                                                                    1. Nonsteroidal Anti-Inflammatory Drugs
                                                                                                      1. Corticosteroids
                                                                                                        1. Biologics
                                                                                                        2. China Anti-Inflammatory Therapeutics Market, By Indications
                                                                                                          1. Arthritis
                                                                                                            1. Psoriasis
                                                                                                              1. Respiratory Diseases
                                                                                                                1. Multiple Sclerosis
                                                                                                                  1. Anti-inflammatory Bowel Disease
                                                                                                                    1. Others
                                                                                                                  2. Korea
                                                                                                                  3. Japan
                                                                                                                  4. India
                                                                                                                  5. Australia
                                                                                                                  6. Taiwan
                                                                                                                  7. South East Asia
                                                                                                                  8. Rest of Asia-Pacific
                                                                                                                2. Middle East and Africa
                                                                                                                  1. Middle East and Africa Anti-Inflammatory Therapeutics Market, By Drug Class
                                                                                                                    1. Nonsteroidal Anti-Inflammatory Drugs
                                                                                                                      1. Corticosteroids
                                                                                                                        1. Biologics
                                                                                                                        2. Middle East and Africa Anti-Inflammatory Therapeutics Market, By Indications
                                                                                                                          1. Arthritis
                                                                                                                            1. Psoriasis
                                                                                                                              1. Respiratory Diseases
                                                                                                                                1. Multiple Sclerosis
                                                                                                                                  1. Anti-inflammatory Bowel Disease
                                                                                                                                    1. Others
                                                                                                                                    2. UAE
                                                                                                                                      1. UAE Anti-Inflammatory Therapeutics Market, By Drug Class
                                                                                                                                        1. Nonsteroidal Anti-Inflammatory Drugs
                                                                                                                                          1. Corticosteroids
                                                                                                                                            1. Biologics
                                                                                                                                            2. UAE Anti-Inflammatory Therapeutics Market, By Indications
                                                                                                                                              1. Arthritis
                                                                                                                                                1. Psoriasis
                                                                                                                                                  1. Respiratory Diseases
                                                                                                                                                    1. Multiple Sclerosis
                                                                                                                                                      1. Anti-inflammatory Bowel Disease
                                                                                                                                                        1. Others
                                                                                                                                                      2. Turkey
                                                                                                                                                      3. Saudi Arabia
                                                                                                                                                      4. South Africa
                                                                                                                                                      5. Egypt
                                                                                                                                                      6. Nigeria
                                                                                                                                                      7. Rest of MEA
                                                                                                                                                    2. LATAM
                                                                                                                                                      1. LATAM Anti-Inflammatory Therapeutics Market, By Drug Class
                                                                                                                                                        1. Nonsteroidal Anti-Inflammatory Drugs
                                                                                                                                                          1. Corticosteroids
                                                                                                                                                            1. Biologics
                                                                                                                                                            2. LATAM Anti-Inflammatory Therapeutics Market, By Indications
                                                                                                                                                              1. Arthritis
                                                                                                                                                                1. Psoriasis
                                                                                                                                                                  1. Respiratory Diseases
                                                                                                                                                                    1. Multiple Sclerosis
                                                                                                                                                                      1. Anti-inflammatory Bowel Disease
                                                                                                                                                                        1. Others
                                                                                                                                                                        2. Brazil
                                                                                                                                                                          1. Brazil Anti-Inflammatory Therapeutics Market, By Drug Class
                                                                                                                                                                            1. Nonsteroidal Anti-Inflammatory Drugs
                                                                                                                                                                              1. Corticosteroids
                                                                                                                                                                                1. Biologics
                                                                                                                                                                                2. Brazil Anti-Inflammatory Therapeutics Market, By Indications
                                                                                                                                                                                  1. Arthritis
                                                                                                                                                                                    1. Psoriasis
                                                                                                                                                                                      1. Respiratory Diseases
                                                                                                                                                                                        1. Multiple Sclerosis
                                                                                                                                                                                          1. Anti-inflammatory Bowel Disease
                                                                                                                                                                                            1. Others
                                                                                                                                                                                          2. Mexico
                                                                                                                                                                                          3. Argentina
                                                                                                                                                                                          4. Chile
                                                                                                                                                                                          5. Colombia
                                                                                                                                                                                          6. Rest of LATAM

                                                                                                                                                                                      Related Reports

                                                                                                                                                                                      Global Report
                                                                                                                                                                                      The global anti-VEGF therapeutics market size was valued at USD 12.3 billion in 2022. It is estimated to reach USD 13.7 billion by 2031, growing at a CAGR of 0.6% during the forecast period (2023–2031). The human body naturally produces VEGF,
                                                                                                                                                                                      Buy Now

                                                                                                                                                                                      Purchase Benefits

                                                                                                                                                                                      • Eligible for a free updated report next year
                                                                                                                                                                                      • Completely customizable scope
                                                                                                                                                                                      • 30% discount on your next purchase
                                                                                                                                                                                      • Dedicated account manager
                                                                                                                                                                                      • Query resolution within 24 hours
                                                                                                                                                                                      • Permission to print the report

                                                                                                                                                                                      We are featured on :

                                                                                                                                                                                      www.straitsresearch.com
                                                                                                                                                                                      © Copyright . All rights Reserved.